These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

262 related items for PubMed ID: 19730209

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Effects of combined ovariectomy with dexamethasone on rat lumbar vertebrae.
    Ren H, Liang D, Shen G, Yao Z, Jiang X, Tang J, Cui J, Lin S.
    Menopause; 2016 Apr; 23(4):441-50. PubMed ID: 26694734
    [Abstract] [Full Text] [Related]

  • 23. Treatment with human parathyroid hormone (1-34) for 18 months increases cancellous bone volume and improves trabecular architecture in ovariectomized cynomolgus monkeys (Macaca fascicularis).
    Jerome CP, Burr DB, Van Bibber T, Hock JM, Brommage R.
    Bone; 2001 Feb; 28(2):150-9. PubMed ID: 11182372
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Effects of different dosages of parathyroid hormone-related protein 1-34 on the bone metabolism of the ovariectomized rat model of osteoporosis.
    Xu J, Rong H, Ji H, Wang D, Wang J, Zhang W, Zhang Y.
    Calcif Tissue Int; 2013 Sep; 93(3):276-87. PubMed ID: 23807531
    [Abstract] [Full Text] [Related]

  • 27. Parathyroid hormone (1-34) increases vertebral bone mass, compressive strength, and quality in old rats.
    Ejersted C, Andreassen TT, Hauge EM, Melsen F, Oxlund H.
    Bone; 1995 Dec; 17(6):507-11. PubMed ID: 8835302
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Effects of continual intermittent administration of parathyroid hormone on implant stability in the presence of osteoporosis: an in vivo study using resonance frequency analysis in a rabbit model.
    Oki Y, Doi K, Makihara Y, Kobatake R, Kubo T, Tsuga K.
    J Appl Oral Sci; 2017 Dec; 25(5):498-505. PubMed ID: 29069147
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Bisphosphonate tiludronate increases bone strength by improving mass and structure in established osteopenia after ovariectomy in rats.
    Ohnishi H, Nakamura T, Narusawa K, Murakami H, Abe M, Barbier A, Suzuki K.
    Bone; 1997 Oct; 21(4):335-43. PubMed ID: 9315337
    [Abstract] [Full Text] [Related]

  • 33. Accretion of bone mass and strength with parathyroid hormone prior to the onset of estrogen deficiency can provide temporary beneficial effects in skeletally mature rats.
    Shen V, Birchman R, Liang XG, Wu DD, Dempster DW, Lindsay R.
    J Bone Miner Res; 1998 May; 13(5):883-90. PubMed ID: 9610753
    [Abstract] [Full Text] [Related]

  • 34. Temporal expression of the anabolic action of PTH in cancellous bone of ovariectomized rats.
    Meng XW, Liang XG, Birchman R, Wu DD, Dempster DW, Lindsay R, Shen V.
    J Bone Miner Res; 1996 Apr; 11(4):421-9. PubMed ID: 8992872
    [Abstract] [Full Text] [Related]

  • 35. Effects of sequential osteoporosis treatments on trabecular bone in adult rats with low bone mass.
    Amugongo SK, Yao W, Jia J, Lay YA, Dai W, Jiang L, Walsh D, Li CS, Dave NK, Olivera D, Panganiban B, Ritchie RO, Lane NE.
    Osteoporos Int; 2014 Jun; 25(6):1735-50. PubMed ID: 24722767
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. The influence of alendronate on spine fusion in an osteoporotic animal model.
    Nakao S, Minamide A, Kawakami M, Boden SD, Yoshida M.
    Spine (Phila Pa 1976); 2011 Aug 15; 36(18):1446-52. PubMed ID: 21240048
    [Abstract] [Full Text] [Related]

  • 40. LY353381 x HCl: an improved benzothiophene analog with bone efficacy complementary to parathyroid hormone-(1-34).
    Sato M, Zeng GQ, Rowley E, Turner CH.
    Endocrinology; 1998 Nov 15; 139(11):4642-51. PubMed ID: 9794476
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.